Drugs / rifampcin
rifampcin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06819449 Comparator | Dec 2024 → Dec 2025 overdue | leprosy | South Valley University | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rifampcin | “( dapsone \_ clofazimine \_ rifampcin) then to assess the role of Rab 32 gene.” NCT06819449 ↗ |
| Known as | rifampicin | “The primary bactericidal effect of rifampicin (RMP), a semi-synthetic derivative of rifamycin B, is observed.” NCT06819449 ↗ |
| Known as | RMP | “The primary bactericidal effect of rifampicin (RMP), a semi-synthetic derivative of rifamycin B, is observed.” NCT06819449 ↗ |
| Action | Inhibit | “It functions by preventing the RNA-polymerase enzyme in the bacillus from growing.” NCT06819449 ↗ |
| Modality | Small molecule | “The primary bactericidal effect of rifampicin (RMP), a semi-synthetic derivative of rifamycin B, is observed.” NCT06819449 ↗ |